Illumina Inc. (ILMN) Releases FY14 Earnings Guidance
Illumina Inc. (NASDAQ:ILMN) updated its FY14 earnings guidance on Tuesday. The company provided EPS guidance of $2.00-$2.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.06, Analyst Ratings Net reports. The company issued revenue guidance of $1.63-$1.66 billion, compared to the consensus revenue estimate of $1.64 billion.
Shares of Illumina Inc. (NASDAQ:ILMN) traded up 3.05% on Tuesday, hitting $144.53. 3,570,546 shares of the company’s stock traded hands. Illumina Inc. has a 52-week low of $48.00 and a 52-week high of $148.48. The stock’s 50-day moving average is $114.8 and its 200-day moving average is $91.78. The company has a market cap of $18.268 billion and a price-to-earnings ratio of 167.36.
Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Tuesday, January 28th. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter last year, the company posted $0.42 earnings per share. Illumina’s revenue was up 25.1% compared to the same quarter last year. On average, analysts predict that Illumina Inc. will post $1.78 earnings per share for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Leerink Swann raised their price target on shares of Illumina from $110.00 to $140.00 in a research note to investors on Friday, January 17th. On a related note, analysts at Bank of America Corp. raised their price target on shares of Illumina from $125.00 to $165.00 in a research note to investors on Friday, January 17th. Finally, analysts at Robert W. Baird raised their price target on shares of Illumina from $87.00 to $137.00 in a research note to investors on Friday, January 17th. Seven research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus target price of $113.11.
In other Illumina news, CEO Jay Flatley sold 30,000 shares of the stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $142.30, for a total value of $4,269,000.00. Following the completion of the transaction, the chief executive officer now directly owns 399,509 shares of the company’s stock, valued at approximately $56,850,131. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.